Total Payments
$67,308
2024 Payments
$2,195
Companies
24
Transactions
222
Medicare Patients
8,999
Medicare Billing
$860,011
Payment Breakdown by Category
Other$44,000 (65.4%)
Travel$10,229 (15.2%)
Consulting$8,881 (13.2%)
Food & Beverage$4,185 (6.2%)
Education$13.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,000 | 20 | 65.4% |
| Travel and Lodging | $10,229 | 38 | 15.2% |
| Consulting Fee | $8,881 | 5 | 13.2% |
| Food and Beverage | $4,185 | 158 | 6.2% |
| Education | $13.68 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $39,622 | 80 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $14,624 | 20 | $0 (2020) |
| Abbott Laboratories | $8,147 | 21 | $0 (2022) |
| Medtronic, Inc. | $3,406 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $261.36 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $233.97 | 16 | $0 (2024) |
| Boston Scientific Corporation | $188.91 | 9 | $0 (2024) |
| PFIZER INC. | $135.64 | 10 | $0 (2021) |
| AtriCure, Inc. | $127.78 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $127.35 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,195 | 20 | Medtronic, Inc. ($2,040) |
| 2023 | $341.78 | 10 | Medtronic, Inc. ($148.87) |
| 2022 | $406.89 | 19 | Medtronic, Inc. ($143.20) |
| 2021 | $1,232 | 13 | Medtronic, Inc. ($1,074) |
| 2020 | $861.26 | 14 | Medtronic Vascular, Inc. ($758.35) |
| 2019 | $8,630 | 28 | Medtronic Vascular, Inc. ($8,259) |
| 2018 | $21,570 | 46 | Medtronic Vascular, Inc. ($17,374) |
| 2017 | $32,073 | 72 | Medtronic Vascular, Inc. ($13,231) |
All Payment Transactions
222 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.66 | General |
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/24/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/06/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Cardiovascular | ||||||
| 04/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.03 | General |
| Category: Cardiovascular | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/30/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $400.00 | General |
| Category: Ablation | ||||||
| 01/30/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $280.00 | General |
| Category: Ablation | ||||||
| 01/30/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $54.31 | General |
| Category: Ablation | ||||||
| 01/30/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $33.62 | General |
| Category: Ablation | ||||||
| 01/25/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $116.26 | General |
| 01/25/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $9.78 | General |
| 01/24/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $173.11 | General |
| Category: Ablation | ||||||
| 01/24/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: Ablation | ||||||
| 01/11/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $451.30 | General |
| Category: Ablation | ||||||
| 01/11/2024 | Medtronic, Inc. | PULSESELECT (Device) | Travel and Lodging | In-kind items and services | $450.26 | General |
| Category: Ablation | ||||||
| 12/10/2023 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $148.87 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/08/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: Medical Device | ||||||
| 10/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,995 | 2,559 | $705,441 | $184,277 |
| 2022 | 31 | 2,343 | 3,056 | $811,401 | $215,281 |
| 2021 | 30 | 2,364 | 3,076 | $830,169 | $238,821 |
| 2020 | 30 | 2,297 | 2,913 | $745,096 | $221,632 |
Total Patients
8,999
Total Services
11,604
Medicare Billing
$860,011
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 50 | 54 | $197,100 | $42,123 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 167 | 212 | $61,480 | $29,788 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 177 | $36,285 | $17,379 | 47.9% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 16 | 16 | $48,960 | $11,946 | 24.4% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 37 | 37 | $50,690 | $9,411 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $18,460 | $8,840 | 47.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 19 | 19 | $33,725 | $7,964 | 23.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 80 | $16,000 | $7,739 | 48.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 120 | 122 | $55,510 | $6,645 | 12.0% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 14 | 14 | $21,630 | $5,370 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 78 | $11,700 | $5,061 | 43.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 319 | 425 | $34,000 | $4,867 | 14.3% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 15 | 18 | $24,570 | $4,578 | 18.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 519 | 663 | $19,890 | $4,263 | 21.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $9,000 | $4,124 | 45.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 77 | 144 | $12,960 | $2,300 | 17.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 46 | 83 | $8,300 | $1,755 | 21.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 32 | 61 | $12,810 | $1,470 | 11.5% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 20 | 20 | $9,000 | $1,438 | 16.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 24 | 51 | $3,825 | $1,374 | 35.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,575 | $1,282 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 14 | $2,870 | $1,118 | 39.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 16 | $3,040 | $1,067 | 35.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 24 | 51 | $4,080 | $902.15 | 22.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 44 | 48 | $3,120 | $765.46 | 24.5% |
About Dr. Robert Sangrigoli, MD
Dr. Robert Sangrigoli, MD is a Cardiovascular Disease healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619976768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sangrigoli, MD has received a total of $67,308 in payments from pharmaceutical and medical device companies, with $2,195 received in 2024. These payments were reported across 222 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,000).
As a Medicare-enrolled provider, Sangrigoli has provided services to 8,999 Medicare beneficiaries, totaling 11,604 services with total Medicare billing of $860,011. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Doylestown, PA
- Active Since 07/20/2005
- Last Updated 03/02/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1619976768
Products in Payments
- Arctic Front (Device) $36,987
- XARELTO (Drug) $14,624
- Cardiac Mapping System (Device) $7,902
- PULSESELECT (Device) $1,909
- Micra (Device) $1,374
- ELIQUIS (Drug) $301.59
- SelectSecure (Device) $290.41
- ENTRESTO (Drug) $179.06
- CareLink Express (Device) $159.36
- COBALT DR MRI SURESCAN (Device) $148.87
- ATRICURE SYNERGY ABLATION SYSTEM (Device) $127.78
- PRALUENT (Drug) $112.97
- AZURE XT DR MRI SURESCAN (Device) $101.29
- WATCHMAN Access System (Device) $99.33
- LEQVIO (Drug) $82.30
- UPTRAVI (Drug) $53.31
- BRILINTA (Drug) $52.75
- EnSite Precision Cardiac Mapping System (Device) $47.36
- Ensite Cardiac Mapping System (Device) $47.29
- ENSITE PRECISION (Device) $41.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Doylestown
Dr. Stephen Sloan, Md, Facc, MD, FACC
Cardiovascular Disease — Payments: $105,730
Cardiovascular Disease $105,730
Dr. James Kmetzo, M.d, Facc, M.D, FACC
Cardiovascular Disease — Payments: $84,870
Cardiovascular Disease $84,870
Philip Wiener, D.o, D.O
Cardiovascular Disease — Payments: $60,970
Cardiovascular Disease $60,970
John Harding, M.d, M.D
Cardiovascular Disease — Payments: $45,223
Cardiovascular Disease $45,223
Irfan Khurram, M.d, M.D
Cardiovascular Disease — Payments: $37,511
Cardiovascular Disease $37,511
Peter Dibattiste
Cardiovascular Disease — Payments: $34,273
Cardiovascular Disease $34,273